Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line

被引:79
作者
Zhao, Da-Long
Zou, Li-Bo
Lin, Sheng
Shi, Han-Gong
Zhu, Hai-Bo
机构
[1] Chinese Acad Med Sci, Chinese Herbal Med Affiliated Minist Educ, Key Lab Bioact Subst & Reources Utilizat, Inst Mat Med, Beijing 100050, Peoples R China
[2] Peking Union Med Coll, Beijing 100050, Peoples R China
[3] Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R China
基金
中国国家自然科学基金;
关键词
esculin; Parkinson's diseased; dopamine; apoptosis; reactive oxygen species;
D O I
10.1016/j.neuropharm.2007.07.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopamine (DA), as a neurotoxin, can elicit severe Parkinson's disease-like syndrome by elevating intracellular reactive oxygen species (ROS) levels and apoptotic activity. In this study, we examined the effect of esculin, which was extracted from Fraxinus sielboldiana blume, on DA-induced cytotoxicity and the underlying mechanism in human neuroblastoma SH-SY5Y cells. Our results suggest that the protective effects of esculin (10(-7), 10(-6) and 10(-5) M) on DA-induced cytotoxicity may be ascribed to its anti-oxidative properties by reducing ROS level, and its anti-apoptotic effect via protecting mitochondrion membrane potential (Delta Psi m), enhancing superoxide dismutaese (SOD) activity and reduced glutathione (GSH) levels, and regulating P53, Bax and Bcl-2 expression. In addition, esculin inhibited the release of cytochrome c and apoptosis-inducing factor (AIF), and the protein expression of activated caspase 3. These data indicate that esculin may provide a useful therapeutic strategy for the treatment of progressive neurodegenerative diseases such as Parkinson's disease (PD). (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:724 / 732
页数:9
相关论文
共 40 条
[1]   Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease? [J].
Barzilai, A ;
Melamed, E ;
Shirvan, A .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2001, 21 (03) :215-235
[2]  
COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.iy.10.040192.001411
[3]   The BCL2 family: Regulators of the cellular life-or-death switch [J].
Cory, S ;
Adams, JM .
NATURE REVIEWS CANCER, 2002, 2 (09) :647-656
[4]   Prevalence of parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON collaborative study [J].
deRijk, MC ;
Tzourio, C ;
Breteler, MMB ;
Dartigues, JF ;
Amaducci, L ;
LopezPousa, S ;
ManubensBertran, JM ;
Alperovitch, A ;
Rocca, WA .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (01) :10-15
[5]   COMPARATIVE-STUDIES ON THE MECHANISMS OF PARAQUAT AND 1-METHYL-4-PHENYLPYRIDINE (MPP+) CYTOTOXICITY [J].
DIMONTE, D ;
SANDY, MS ;
EKSTROM, G ;
SMITH, MT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 137 (01) :303-309
[6]   p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism [J].
Duan, WZ ;
Zhu, XX ;
Ladenheim, B ;
Yu, QS ;
Guo, ZH ;
Oyler, J ;
Cutler, RG ;
Cadet, JL ;
Greig, NH ;
Mattson, MP .
ANNALS OF NEUROLOGY, 2002, 52 (05) :597-606
[7]   Dopamine induces autophagic cell death and α-synuclein increase in human neuroblastoma SH-SY5Y cells [J].
Gómez-Santos, C ;
Ferrer, I ;
Santidrián, AF ;
Barrachina, M ;
Gil, J ;
Ambrosio, S .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 73 (03) :341-350
[8]   Apoptosis in neuronal cells: role of caspases [J].
Gorman, AM ;
Orrenius, S ;
Ceccatelli, S .
NEUROREPORT, 1998, 9 (10) :R49-R55
[9]  
Graeber MB, 2002, BRAIN PATHOL, V12, P385
[10]  
Han BS, 2003, J NEUROSCI, V23, P5069